arXiv (OAI Expanded)
open access
Machine learning for RNA-targeting drug design
Targeting RNA with small molecules offers significant therapeutic potential. Machine learning could substantially accelerate preclinical drug discovery, from hit identification to lead optimization. Yet a fundamental limitation emerges: drug design machine learning models, tailored for proteins,
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Opportunities for artificial intelligence and synthetic biology in designing living drug delivery systems.#301607
- From RNA design to delivery: Computational strategies for functional RNA therapeutics#784652
- Engineering polymeric RNA scaffolds as programmable combinatorial innate immune agonists.#13627
- RECENT ADVANCES IN STRUCTURE-BASED DRUG DESIGN AND COMPUTATIONAL APPROACHES IN MEDICINAL CHEMISTRY FOR NOVEL THERAPEUTIC DEVELOPMENT#20953
- RECENT ADVANCES IN STRUCTURE-BASED DRUG DESIGN AND COMPUTATIONAL APPROACHES IN MEDICINAL CHEMISTRY FOR NOVEL THERAPEUTIC DEVELOPMENT#20952
Record · ID 1122986
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive